Current Impact of Tariffs on Pricing and Availability
Rising Costs and Uncertainty Due to Tariffs
Broad Tariff Increases: The U.S. has implemented a 10% universal tariff on all imported goods, with additional country-specific tariffs of 100 %+ on China, 26% on India, 20% on the European Union, and 25% on Canada and Mexico. More at tariff.bigbenmedical.com
Specific Medical Equipment Affected:
All equipment sources outside the US or those with a portion of their supply chain offshore.
Imagery equipment will be impacted as most large manufacturers are in Europe.
Turning to the used market will also be problematic, as the secondary markets have already significantly increased the value of used equipment.
Other Equipment: Diagnostic tools, blood pressure cuffs, and sterile drapes are also subject to increased tariffs.
Industry Impact: These tariffs affect approximately 75% of U.S.-marketed medical equipment and devices, many manufactured abroad, leading to increased healthcare costs.
Supply Chain Disruptions and Delays
Raw Material Tariffs: Tariffs on essential components like aluminum, steel, and semiconductors disrupt the medical equipment supply chain, leading to higher production costs and potential shortages in the medical device and diagnostic industry.
Manufacturer Responses:
Johnson & Johnson: Anticipates $400 million in tariff-related expenses in 2025, primarily affecting its medical technology division.
Abbott Laboratories: Maintains its profit forecast despite global tariff uncertainties, investing $500 million in U.S. manufacturing to mitigate risks.
Impact on Healthcare Providers
Increased Operational Costs: Hospitals and clinics face higher prices for essential equipment, straining budgets and potentially leading to increased patient costs.
Potential Shortages: Tariffs may lead to delays or limited access to necessary medical equipment, affecting patient care quality, or scenarios where the right life-saving equipment is not available.
Strategic Responses
Domestic Production Initiatives: Companies invest in U.S.-based manufacturing to reduce reliance on imported goods and mitigate tariff impacts.
Policy Advocacy: Industry groups call for tax incentives and regulatory support to encourage domestic production and address supply chain vulnerabilities.